ZACCARDELLI DAVID (President and CEO) sold 5.8% of their position (870.67K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $4.36M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/6/2024ACC: 0001104659-24-126372
DirectorOfficer· President and CEO
Since Jan 2021
-870.67K
Net shares
Net seller
$4.36M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
870.67K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−67.61K
Price / share
$5.00
Trade value
$338.16K
% of position
0.4%
12/4/2024
15.08M→15.01M
Ordinary Shares
Direct
Shares
−640.26K
Price / share
$5.01
Trade value
$3.21M
% of position
4.3%
12/5/2024
15.01M→14.37M
Ordinary Shares
Direct
Shares
−162.80K
Price / share
$5.01
Trade value
$815.40K
% of position
1.1%
12/6/2024
14.37M→14.20M
Total
Net shares
−870.67K
Net value
-$4.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/4/2024 | S · Sale | −67.61K | $5.00 | $338.16K | 0.4% | 15.08M | 15.01M |
| Ordinary Shares Direct | 12/5/2024 | S · Sale | −640.26K | $5.01 | $3.21M | 4.3% | 15.01M | 14.37M |
| Ordinary Shares Direct | 12/6/2024 | S · Sale | −162.80K | $5.01 | $815.40K | 1.1% | 14.37M | 14.20M |
| Total | −870.67K | -$4.36M | ||||||
Derivative Transactions0
No derivative transactions reported